Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Correction: Secondary outcomes...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

Bibliographic Details
Main Authors: Laura Dixon, Sara Bartel, Victoria Brown, Sarrah I. Ali, Susan Gamberg, Andrea Murphy, Katherine L. Brewer, Susan L. McElroy, Allan Kaplan, Abraham Nunes, Aaron R. Keshen
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Eating Disorders
Online Access:https://doi.org/10.1186/s40337-023-00926-5
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1186/s40337-023-00926-5

Similar Items

  • Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
    by: Laura Dixon, et al.
    Published: (2023-05-01)
  • Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation
    by: Matthew D. Lyons MD, et al.
    Published: (2017-05-01)
  • Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
    by: Michael Pennick
    Published: (2010-06-01)
  • Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
    by: Jadwiga Najib, et al.
    Published: (2017-08-01)
  • Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate
    by: Guilherme A. Eger, et al.
    Published: (2016-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs